Qbrelis Approval History
- FDA approved: Yes (First approved July 29th, 2016)
- Brand name: Qbrelis
- Generic name: lisinopril
- Dosage form: Oral Solution
- Company: Silvergate Pharmaceuticals, Inc.
- Treatment for: High Blood Pressure, Heart Failure, Heart Attack
Qbrelis (lisinopril) is an oral solution formulation of the approved angiotensin converting enzyme (ACE) inhibitor lisinopril indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older, adjunct therapy for heart failure, and treatment of acute myocardial infarction in adults.
Development History and FDA Approval Process for Qbrelis
|Jul 29, 2016||FDA Approves Qbrelis (lisinopril) Oral Solution for Pediatric Patients 6 Years of Age and Older|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.